4D MOLECULAR THERAPEUTICS IN

Ticker: FDMT CUSIP: 35104E100 Class: Common Stock

Redmile Group, LLC's Holding History (CIK: 0001425738)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025

Shares 112,168 Value ($000) $416 Avg Close $3.52 Range $2.23 - $5.10

Q1 2025

Shares 997,235 Value ($000) $3,221 Avg Close $4.71 Range $3.17 - $6.91

Q4 2024

Shares 1,196,910 Value ($000) $6,667 Avg Close $7.85 Range $5.22 - $10.78

Q3 2024

Shares 1,262,090 Value ($000) $13,643 Avg Close $16.60 Range $10.56 - $28.93

Q2 2024

Shares 1,073,435 Value ($000) $22,531 Avg Close $25.09 Range $20.33 - $31.87

Q1 2024

Shares 1,261,427 Value ($000) $40,189 Avg Close $25.51 Range $16.64 - $36.25

Period	Shares	Value ($000)	Average Close	Price Range
Q2 2025	112,168	$416	$3.52	$2.23 - $5.10
Q1 2025	997,235	$3,221	$4.71	$3.17 - $6.91
Q4 2024	1,196,910	$6,667	$7.85	$5.22 - $10.78
Q3 2024	1,262,090	$13,643	$16.60	$10.56 - $28.93
Q2 2024	1,073,435	$22,531	$25.09	$20.33 - $31.87
Q1 2024	1,261,427	$40,189	$25.51	$16.64 - $36.25